The current status of clinical PET imaging
- 1 September 1996
- journal article
- review article
- Published by Elsevier in Clinical Radiology
- Vol. 51 (9) , 603-613
- https://doi.org/10.1016/s0009-9260(96)80052-3
Abstract
No abstract availableThis publication has 81 references indexed in Scilit:
- Triple-head SPECT with 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG): initial evaluation in oncology and comparison with FDG PET.Radiology, 1995
- Whole-body 18F-fluorodeoxyglucose positron emission tomography in preoperative evaluation of lung cancerThe Lancet, 1994
- FDG-PET for predicting the prognosis of malignant lymphomaAnnals of Nuclear Medicine, 1994
- Triple approach in the diagnosis of dominant breast masses: Combined physical examination, mammography, and fine‐needle aspirationJournal of Surgical Oncology, 1994
- Positron emission tomography and breast masses: Comparison with clinical, mammographic, and pathological findingsAnnals of Surgical Oncology, 1994
- Reasons underlying negative mammography in patients with palpable breast cancerClinical Radiology, 1994
- Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT.Radiology, 1994
- Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning.Radiology, 1993
- Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose.Radiology, 1992
- FDG-PET in the Selection of Brain Lesions for BiopsyJournal of Computer Assisted Tomography, 1991